Assessment of EN-RAGE, sRAGE, and its isoforms: cRAGE, esRAGE in obese patients treated by moderate caloric restriction combined with physical activity conducted in hospital condition.

EN-RAGE Moderate calorie restriction Obesity cRAGE esRAGE sRAGE

Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
31 May 2024
Historique:
received: 19 03 2024
revised: 15 05 2024
accepted: 24 05 2024
medline: 2 6 2024
pubmed: 2 6 2024
entrez: 1 6 2024
Statut: aheadofprint

Résumé

AGEs, their receptor (RAGE), and the extracellular newly identified receptor for AGEs product-binding protein (EN-RAGE) are implicated in the pathogenesis of inflammation. We analyzed serum EN-RAGE, soluble RAGE (sRAGE), and their isoforms: endogenous secretory - esRAGE and cleaved - cRAGE concentrations in lean controls (n = 74) and in patients with obesity (n = 71) treated for three weeks with moderate calorie restriction (CR) combined with physical activity in a hospital condition. Using the ELISA method, serum sRAGE, esRAGE, and EN-RAGE were measured before and after CR. The serum level of sRAGE and esRAGE in patients with obesity was lower than that in non-obese individuals, contrary to cRAGE. EN-RAGE concentration was about three times higher in obese patients. Gradually, a rise in BMI resulted in sRAGE, esRAGE reduction, and EN-RAGE increase. The sRAGE concentration was sex-dependent, indicating a higher value in lean men. A moderate negative correlation was observed between BMI and all RAGE isoforms, whereas EN-RAGE displays a positive correlation. CR resulted in an expected decrease in anthropometric, metabolic, and proinflammatory parameters and EN-RAGE, but no RAGE isoforms. The ratio EN-RAGE/sRAGE was higher in obese humans than in control and was not modified by CR. Obesity decreases sRAGE and esRAGE and increases EN-RAGE concentration. Moderate CR and physical activity by decreasing inflammation reduces EN-RAGE but is insufficient to increase sRAGE and esRAGE to the extent observed in lean patients. EN-RAGE instead of sRAGE could be helpful to indicate a better outcome of moderate dietary intervention in obese subjects.

Sections du résumé

BACKGROUND BACKGROUND
AGEs, their receptor (RAGE), and the extracellular newly identified receptor for AGEs product-binding protein (EN-RAGE) are implicated in the pathogenesis of inflammation.
AIM OBJECTIVE
We analyzed serum EN-RAGE, soluble RAGE (sRAGE), and their isoforms: endogenous secretory - esRAGE and cleaved - cRAGE concentrations in lean controls (n = 74) and in patients with obesity (n = 71) treated for three weeks with moderate calorie restriction (CR) combined with physical activity in a hospital condition.
METHODS METHODS
Using the ELISA method, serum sRAGE, esRAGE, and EN-RAGE were measured before and after CR.
RESULTS RESULTS
The serum level of sRAGE and esRAGE in patients with obesity was lower than that in non-obese individuals, contrary to cRAGE. EN-RAGE concentration was about three times higher in obese patients. Gradually, a rise in BMI resulted in sRAGE, esRAGE reduction, and EN-RAGE increase. The sRAGE concentration was sex-dependent, indicating a higher value in lean men. A moderate negative correlation was observed between BMI and all RAGE isoforms, whereas EN-RAGE displays a positive correlation. CR resulted in an expected decrease in anthropometric, metabolic, and proinflammatory parameters and EN-RAGE, but no RAGE isoforms. The ratio EN-RAGE/sRAGE was higher in obese humans than in control and was not modified by CR.
CONCLUSION CONCLUSIONS
Obesity decreases sRAGE and esRAGE and increases EN-RAGE concentration. Moderate CR and physical activity by decreasing inflammation reduces EN-RAGE but is insufficient to increase sRAGE and esRAGE to the extent observed in lean patients. EN-RAGE instead of sRAGE could be helpful to indicate a better outcome of moderate dietary intervention in obese subjects.

Identifiants

pubmed: 38823153
pii: S1043-4666(24)00168-6
doi: 10.1016/j.cyto.2024.156665
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156665

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Dominika Kanikowska (D)

Department of Pathophysiology, Poznań University of Medical Sciences, Poznań, Poland. Electronic address: dkanikowska@ump.edu.pl.

Alina Kanikowska (A)

Department of Internal Diseases, Metabolism and Nutrition, Poznań University of Medical Science, Poznań, Poland.

Zofia Strojny (Z)

Department of Conservative Dentistry and Endodontics, Poznań University of Medical Sciences, Poznań, Poland.

Edyta Kawka (E)

Department of Pathophysiology, Poznań University of Medical Sciences, Poznań, Poland.

Agnieszka Zawada (A)

Department of Internal Diseases, Metabolism and Nutrition, Poznań University of Medical Science, Poznań, Poland.

Rafał Rutkowski (R)

Department of Pathophysiology, Poznań University of Medical Sciences, Poznań, Poland.

Monika Litwinowicz (M)

Department of Pathophysiology, Poznań University of Medical Sciences, Poznań, Poland.

Maki Sato (M)

Institutional Research, Aichi Medical University School of Medicine, Aichi, Japan.

Marian Grzymisławski (M)

Department of Internal Diseases, Metabolism and Nutrition, Poznań University of Medical Science, Poznań, Poland.

Andrzej Bręborowicz (A)

Department of Pathophysiology, Poznań University of Medical Sciences, Poznań, Poland; Collegium Medicum, Zielona Góra University, Zielona Góra, Poland.

Janusz Witowski (J)

Department of Pathophysiology, Poznań University of Medical Sciences, Poznań, Poland.

Katarzyna Korybalska (K)

Department of Pathophysiology, Poznań University of Medical Sciences, Poznań, Poland.

Classifications MeSH